4,744 research outputs found

    Report of the Second International Symposium on Molecular Epidemiology in Childhood Leukaemia and Embryonal Tumours, Rio de Janeiro, Brazil

    Get PDF
    The recent International Symposium on Molecular epidemiology in Embryonal Tumours and Paediatric Leukaemia was held on 4–6 March 2008 in Rio de Janeiro, Brazil. It proved a very productive meeting in which studies relating to genetics, therapeutical trials, identification of risk factors in acute leukaemia neuroblastoma and Wilms’ tumours were presented. Over 120 participants gathered for three days of fruitful discussions, including representatives of paediatrics, haematology, laboratory, epidemiology and pathology. Debates were held about strategies of applications of important biomarkers for clinical trials. Highlights of each of the scientific presentations are summarized below

    approach chemistry, functional and biological

    Get PDF
    Dithiocarbamates represent a class of compounds that were evaluated in different biomedical applications because of their chemical versatility. For this reason, several pharmacological activities have already been attributed to these compounds, such as antiparasitic, antiviral, antifungal activities, among others. Therefore, compounds that are based on dithiocarbamates have been evaluated in different in vivo and in vitro models as potential new antimicrobials. Thus, the purpose of this review is to present the possibilities of using dithiocarbamate compounds as potential new antitrypanosomatids-drugs, which could be used for the pharmacological control of Chagas disease, leishmaniasis, and African trypanosomiasis.publishersversionpublishe

    Strict protected areas are essential for the conservation of larger and threatened mammals in a priority region of the Brazilian Cerrado

    Get PDF
    ssessing protected area (PA) effectiveness is key to ensure the objectives of habitat protection are being achieved. There is strong evidence that legal protection reduces loss of natural vegetation, but biodiversity loss can still happen without significant changes in vegetation cover. Here we use data from a specifically designed camera trap survey to conduct a counterfactual assessment of PA effectiveness at safeguarding local biodiversity in the Brazilian Cerrado. We surveyed the mammal community in 517 locations at the Sertão Veredas-Peruaçu mosaic, distributed across five strict PAs (264 survey sites in five arrays) and two multiple-use PAs with low management levels (253 survey sites in four arrays). We adopted a multi-species occupancy framework to analyse our dataset while also controlling for confounding factors not directly related to protection. Of the 21 species assessed, nine had higher occupancy in strict PAs, one had higher occupancy in multiple-use PAs, and ten did not respond to protection level. Site species richness was nearly twice as large in areas under stricter protection, with even greater differences for species richness of globally threatened and larger mammals (>15 kg). Overall we demonstrated that the strict PAs surveyed support higher mammal diversity than similar areas under less restrictive management, with a particular strong effect on larger and threatened species. Given that strict PAs cover only 3% of the Cerrado, our results suggest that expanding the area under strict protection is likely to benefit iconic species of the Brazilian savanna, such as the maned wolf and giant anteater

    Le Cinéma en Réalité Virtuelle :

    Get PDF
    RĂ©sumĂ© Le cinĂ©ma en RĂ©alitĂ© Virtuelle (V. R.) est une rencontre entre le cinĂ©ma et un type spĂ©cifique de technologie qui simule les environnements virtuels. Cependant, tous deux revendiquent ce qui leur appartient : le cinĂ©ma, avec son propre langage qui glisse sous ses formes d’expression artistique et la RĂ©alitĂ© Virtuelle qui est polymorphe. Lors de cette rencontre, la diĂ©gĂšse cinĂ©matographique subit un changement et met le langage Ă  l’affĂ»t de nouveaux modes de composition. Il induit d’autres façons de penser le cinĂ©ma, qui doit dĂ©sormais ĂȘtre vĂ©cu de l’intĂ©rieur.Abstract : VR cinema is an interchange between cinema and a specific kind of technology that simulates virtual environments, but both claim what belongs to them, which is proper to the medium. The cinema has its own grammar that slips under its forms of narrative and does not keep so many secrets anymore and Virtual Reality is polymorphic. In this meeting, cinematic diegesis suffers a blow and puts language in wait for a new convention and infers other ways of thinking the cinema, which now, needs to be experienced from the inside

    t(10;11)(p12;q23) KMT2A/NEBL

    Get PDF
    Review on t(10;11)(p12;q23) KMT2A/NEBL, with data on clinics, and the genes involved

    Linhagem celular RC-IAL: sensibilidade de crescimento do vírus da rubéola

    Get PDF
    OBJECTIVE: The rapid growth of the rubella virus in RC-IALÂČ with development of cytopathic effect, in response to rubella virus infection, is described. For purposes of comparison, the rubella virus RA-27/3 strain was titered simultaneously in the RC-IAL, Vero, SIRC and RK13 cell lines. METHODS: Rubella virus RA-27/3 strain are inoculated in the RC-IAL cell line (rabbit Kidney, Institute Adolfo Lutz). Plates containing 1.5x10(5) cells/ml of RC-IAL line were inoculated with 0.1ml s RA-27/3 strain virus containing 1x 10(4)TCID50/0.1ml. A 25% cytopathic effect was observed after 48 hours and 100% after 96 hours. The results obtained were compared to those observed with the SIRC, Vero and RK13 cell lines. Rubella virus was detected by immunohistochemistry. RESULTS: With the results, it was possible to conclude that the RC-IAL cell line is a very good substrate for culturing rubella virus. The cells inoculated with rubella virus were examined by phase contrast microscopy and showed the characteristic rounded, bipolar and multipolar cells. The CPE in RC-IAL was observed in the first 48 hours and the curve of the increased infectivity was practically the same as observed in other cell lines. CONCLUSIONS: These findings are important since this is one the few cell lines described in the literature with a cytopathic effect. So it can be used for antigen preparation and serological testing for the diagnosis of specific rubella antibodies.OBJETIVO: Descreve-se o crescimento do vĂ­rus-padrĂŁo da rubĂ©ola RA-27/3 na linhagem celular RC-IAL, com desenvolvimento de efeito citopĂĄtico em resposta Ă  infecção viral. Para este propĂłsito, o vĂ­rus-padrĂŁo foi titulado simultaneamente nas linhagens celulares Vero, SIRC e RK13. MÉTODOS: O vĂ­rus-padrĂŁo da rubĂ©ola RA-27/3 foi inoculado na linhagem celular RC-IAL (rim de coelho, Instituto Adolfo Lutz). Placas contendo 1,5x10(5) cĂ©lulas/ml foram inoculadas com 0,1 ml do vĂ­rus contendo 1x10(4) DICT50/0,1 ml. O efeito citopĂĄtico correspondente a 25% foi observado apĂłs 48 h e 100% apĂłs 96 h. Os resultados obtidos foram comparados com o crescimento do vĂ­rus nas linhagens celulares SIRC, Vero e RK13. O vĂ­rus da rubĂ©ola na linhagem celular RC-IAL foi detectado por imuno-histoquĂ­mica. RESULTADOS: As cĂ©lulas inoculadas com o vĂ­rus da rubĂ©ola apresentaram efeito citopĂĄtico nas primeiras 48h. As cĂ©lulas apresentaram aspecto arredondado, com formação de alguns prolongamentos citoplasmĂĄticos e sincĂ­cios, produzindo cĂ©lulas multinucleadas. A curva do crescimento da infectividade do vĂ­rus foi praticamente a mesma que a observada nas outras linhagens celulares. CONCLUSÃO: Os resultados obtidos mostram que a linhagem celular RC-IAL Ă© um Ăłtimo substrato para crescimento do vĂ­rus da rubĂ©ola, pois poucas linhagens celulares descritas na literatura apresentam efeito citopĂĄtico considerĂĄvel e podem ser utilizadas para preparação de antĂ­genos e nos testes de diagnĂłstico sorolĂłgico para o vĂ­rus da rubĂ©ola

    Understanding the meaning of medications for patients: The medication experience

    Get PDF
    Objective: To understand and describe the meaning of medications for patients. Methods: A metasynthesis of three different, yet complementary qualitative research studies, was conducted by two researchers. The first study was a phenomenological study of patients’ medication experiences that used unstructured interviews. The second study was an ethnographic study of pharmaceutical care practice, which included participant observation, in-depth interviews and focus groups with patients of pharmaceutical care. The third was a phenomenological study of the chronic illness experience of medically uninsured individuals in the United States and included an explicit aim to understand the medication experience within that context. The two researchers who conducted these three qualitative studies that examined the medication experience performed the meta-synthesis. The process began with the researchers reviewing the themes of the medication experience for each study. The researchers then aggregated the themes to identify the overlapping and similar themes of the medication experience and which themes are sub-themes within another theme versus a unique theme of the medication experience. The researchers then used the analytic technique, “free imaginative variation” to determine the essential, structural themes of the medication experience. Results: The meaning of medications for patients was captured as four themes of the medication experience: a meaningful encounter; bodily effects; unremitting nature; and exerting control. The medication experience is an individual’s subjective experience of taking a medication in his daily life. It begins as an encounter with a medication. It is an encounter that is given meaning before it occurs. The experience may include positive or negative bodily effects. The unremitting nature of a chronic medication often causes an individual to question the need for the medication. Subsequently, the individual may exert control by altering the way he takes the medication and often in part because of the gained expertise with the medication in his own body. Conclusion: The medication experience is a practice concept that serves to understand patients’ experiences and to understand an individual patient’s medication experience and medication-taking behaviors in order to meet his or her medication-related needs
    • 

    corecore